162 related articles for article (PubMed ID: 37620226)
1. In vivo mouse models to study bile acid synthesis and signaling.
Bhattacharya A; Taylor RE; Guo GL
Hepatobiliary Pancreat Dis Int; 2023 Oct; 22(5):466-473. PubMed ID: 37620226
[TBL] [Abstract][Full Text] [Related]
2. Regulation of bile acid metabolism in mouse models with hydrophobic bile acid composition.
Honda A; Miyazaki T; Iwamoto J; Hirayama T; Morishita Y; Monma T; Ueda H; Mizuno S; Sugiyama F; Takahashi S; Ikegami T
J Lipid Res; 2020 Jan; 61(1):54-69. PubMed ID: 31645370
[TBL] [Abstract][Full Text] [Related]
3. Characterization of individual bile acids in vivo utilizing a novel low bile acid mouse model.
Taylor R; Yang Z; Henry Z; Capece G; Meadows V; Otersen K; Basaly V; Bhattacharya A; Mera S; Zhou P; Joseph L; Yang I; Brinker A; Buckley B; Kong B; Guo GL
Toxicol Sci; 2024 May; 199(2):316-331. PubMed ID: 38526215
[TBL] [Abstract][Full Text] [Related]
4. FXR agonist GW4064 improves liver and intestinal pathology and alters bile acid metabolism in rats undergoing small intestinal resection.
Cao Y; Xiao Y; Zhou K; Yan J; Wang P; Yan W; Cai W
Am J Physiol Gastrointest Liver Physiol; 2019 Aug; 317(2):G108-G115. PubMed ID: 30920307
[TBL] [Abstract][Full Text] [Related]
5. A human-like bile acid pool induced by deletion of hepatic
de Boer JF; Verkade E; Mulder NL; de Vries HD; Huijkman N; Koehorst M; Boer T; Wolters JC; Bloks VW; van de Sluis B; Kuipers F
J Lipid Res; 2020 Mar; 61(3):291-305. PubMed ID: 31506275
[TBL] [Abstract][Full Text] [Related]
6. Hepatic inflammation caused by dysregulated bile acid synthesis is reversible by butyrate supplementation.
Sheng L; Jena PK; Hu Y; Liu HX; Nagar N; Kalanetra KM; French SW; French SW; Mills DA; Wan YY
J Pathol; 2017 Dec; 243(4):431-441. PubMed ID: 28892150
[TBL] [Abstract][Full Text] [Related]
7. Bile acid homeostasis in female mice deficient in
Rizzolo D; Kong B; Taylor RE; Brinker A; Goedken M; Buckley B; Guo GL
Acta Pharm Sin B; 2021 Dec; 11(12):3847-3856. PubMed ID: 35024311
[TBL] [Abstract][Full Text] [Related]
8. Individual bile acids have differential effects on bile acid signaling in mice.
Song P; Rockwell CE; Cui JY; Klaassen CD
Toxicol Appl Pharmacol; 2015 Feb; 283(1):57-64. PubMed ID: 25582706
[TBL] [Abstract][Full Text] [Related]
9. Farnesoid X receptor-induced lysine-specific histone demethylase reduces hepatic bile acid levels and protects the liver against bile acid toxicity.
Kim YC; Fang S; Byun S; Seok S; Kemper B; Kemper JK
Hepatology; 2015 Jul; 62(1):220-31. PubMed ID: 25545350
[TBL] [Abstract][Full Text] [Related]
10. Muricholic bile acids are potent regulators of bile acid synthesis via a positive feedback mechanism.
Hu X; Bonde Y; Eggertsen G; Rudling M
J Intern Med; 2014 Jan; 275(1):27-38. PubMed ID: 24118394
[TBL] [Abstract][Full Text] [Related]
11. Bile Acid Homeostasis in a Cholesterol 7α-Hydroxylase and Sterol 27-Hydroxylase Double Knockout Mouse Model.
Rizzolo D; Buckley K; Kong B; Zhan L; Shen J; Stofan M; Brinker A; Goedken M; Buckley B; Guo GL
Hepatology; 2019 Jul; 70(1):389-402. PubMed ID: 30864232
[TBL] [Abstract][Full Text] [Related]
12. Diurnal variations of mouse plasma and hepatic bile acid concentrations as well as expression of biosynthetic enzymes and transporters.
Zhang YK; Guo GL; Klaassen CD
PLoS One; 2011 Feb; 6(2):e16683. PubMed ID: 21346810
[TBL] [Abstract][Full Text] [Related]
13. Requirement for MLL3 in p53 regulation of hepatic expression of small heterodimer partner and bile acid homeostasis.
Kim DH; Kim J; Lee JW
Mol Endocrinol; 2011 Dec; 25(12):2076-83. PubMed ID: 22034226
[TBL] [Abstract][Full Text] [Related]
14. Bile acids contribute to the development of non-alcoholic steatohepatitis in mice.
Gillard J; Clerbaux LA; Nachit M; Sempoux C; Staels B; Bindels LB; Tailleux A; Leclercq IA
JHEP Rep; 2022 Jan; 4(1):100387. PubMed ID: 34825156
[TBL] [Abstract][Full Text] [Related]
15. Dysregulation of bile acid homeostasis in parenteral nutrition mouse model.
Zhan L; Yang I; Kong B; Shen J; Gorczyca L; Memon N; Buckley BT; Guo GL
Am J Physiol Gastrointest Liver Physiol; 2016 Jan; 310(2):G93-G102. PubMed ID: 26564717
[TBL] [Abstract][Full Text] [Related]
16. Editor's Highlight: Clofibrate Decreases Bile Acids in Livers of Male Mice by Increasing Biliary Bile Acid Excretion in a PPARα-Dependent Manner.
Zhang Y; Lickteig AJ; Csanaky IL; Klaassen CD
Toxicol Sci; 2017 Dec; 160(2):351-360. PubMed ID: 28973556
[TBL] [Abstract][Full Text] [Related]
17. Lactoferrin promotes bile acid metabolism and reduces hepatic cholesterol deposition by inhibiting the farnesoid X receptor (FXR)-mediated enterohepatic axis.
Ling CJ; Xu JY; Li YH; Tong X; Yang HH; Yang J; Yuan LX; Qin LQ
Food Funct; 2019 Nov; 10(11):7299-7307. PubMed ID: 31626262
[TBL] [Abstract][Full Text] [Related]
18. Diabetic cognitive dysfunction is associated with increased bile acids in liver and activation of bile acid signaling in intestine.
Wang X; Wang F; Zhang Y; Xiong H; Zhang Y; Zhuang P; Zhang Y
Toxicol Lett; 2018 May; 287():10-22. PubMed ID: 29382564
[TBL] [Abstract][Full Text] [Related]
19. Decreased bile-acid synthesis in livers of hepatocyte-conditional NADPH-cytochrome P450 reductase-null mice results in increased bile acids in serum.
Cheng X; Zhang Y; Klaassen CD
J Pharmacol Exp Ther; 2014 Oct; 351(1):105-13. PubMed ID: 25034404
[TBL] [Abstract][Full Text] [Related]
20. Impaired Intestinal Farnesoid X Receptor Signaling in Cystic Fibrosis Mice.
Ikpa PT; Doktorova M; Meijsen KF; Nieuwenhuijze NDA; Verkade HJ; Jonker JW; de Jonge HR; Bijvelds MJC
Cell Mol Gastroenterol Hepatol; 2020; 9(1):47-60. PubMed ID: 31470114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]